Enrico Pogliani

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Blood · 2007 · 444 citations

Life Sciences, Genetics, Molecular Genetics +10

Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism

Giancarlo Agnelli, Paolo Prandoni, Cecilia Becattini et al. · Annals of Internal Medicine · 2003 · 399 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Carlo Gambacorti‐Passerini, Philipp le Coutre, Luca Mologni et al. · Blood Cells Molecules and Diseases · 1997 · 319 citations

Life Sciences, Cancer Biology, Oncology +12

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti et al. · Blood · 2008 · 253 citations · Full text

Medicine, Immunology, Oncology +11

Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.

Carlo Gambacorti‐Passerini, Massimo Zucchetti, Domenico Russo et al. · PubMed · 2003 · 231 citations

Medicine, Pharmacokinetics, Pharmacology +13